我要投票 SHINVA新华在医疗器械行业中的票数:94
· 外 推 电 报 ·
2025-01-19 03:08:05 星期日

【SHINVA新华是哪个国家的品牌?】

SHINVA新华是什么牌子?「SHINVA新华」是 山东新华医疗器械股份有限公司 旗下著名品牌。该品牌发源于山东,由创始人许尚峰在1993期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

2002年9月,山东新华医疗器械股份有限公司在上海证券交易所上市,现为中国医疗器械行业协会会长单位。

山东新华医疗器械股份有限公司始终坚持拼搏诚信的齐鲁文化、以用户为中心的现代企业文化为企业核心价值观,用目标鼓舞士气,用发展凝聚人心,用创新提升素质,用文化打造实力,坚定不移地走健康产业之路,坚定不移地走技术创新之路,坚定不移地走资本运作之路,拥有医疗器械及装备、制药装备、医疗服务三大业务板块。

在医疗器械板块,已形成九大配置精良、技术完备的先进产品线,涵盖感染控制、放疗及影像、手术器械及骨科、手术室工程及设备、口腔设备及耗材、体外诊断试剂及仪器、生物材料及耗材、透析设备及耗材、医用环保及其他领域。

制药装备板块,由生物制药、特种输液、中药制剂、固体制剂四大工程技术中心组成,下设八个产品技术分厂和五个控股公司,集制药装备研发、制造及销售为一体。在常规制药装备生产之外,提供着“制药工艺、制药装备、制药工程”三位一体的优质服务;同时,为化学药、生物药、植物药工厂的建设提供整包服务,为客户解决一切后顾之忧。

在医疗服务领域,新华医疗持续提升着品牌竞争力和美誉度。凭借专业的投资、建设、运营及采购和服务平台,打造具有先进医疗理念、前沿科研水平、品牌经营连锁、资源有机融合的现代化医院集团。与此同时,新华医疗也在积极拓展着肾脏健康服务,利用公司专业化、集约化、连锁化的运营优势,为医院提供新技术、新管理、新模式,创建出一系列特色鲜明的肾脏病专科医院和血液透析中心,用无限的责任感和专业度,服务于广大肾病患者。未来,新华医疗,将以集团化、专业化、规范化的全新面貌,为更多患者提供完善医疗服务,成就发展健康产业之路的宏伟梦想。

公司以山东核心区域为研发、制造、营销和管理总部,同时有北京核心区域、上海核心区域。

心系健康,诚信天下。站在新的历史起点上,面对新的发展机遇,新华医疗将一如既往,与时俱进,以自信、创新和拼搏,去勇敢面对困难和挑战,为人类健康事业、为铸造中国医疗器械产业的丰碑、打造世界知名医疗器械生产企业而继续努力奋斗!

英文翻译:In September 2002, Shandong Xinhua medical device Co., Ltd. was listed on the Shanghai Stock Exchange and is now the chairman of China Medical Device Industry Association. Shandong Xinhua Medical Equipment Co., Ltd. always adheres to the Qilu culture of striving for integrity, the modern enterprise culture centered on users as the core values of the enterprise, encourages morale with goals, rallies people with development, improves quality with innovation, builds strength with culture, firmly takes the road of health industry, firmly takes the road of technological innovation, and firmly takes the road of capital The way of operation, with medical devices and equipment, pharmaceutical equipment, medical services three business sectors. In the medical equipment sector, nine advanced product lines with excellent configuration and complete technology have been formed, covering infection control, radiotherapy and imaging, surgical equipment and orthopedics, operating room engineering and equipment, oral equipment and consumables, in vitro diagnostic reagents and instruments, biomaterials and consumables, dialysis equipment and consumables, medical environmental protection and other fields. The pharmaceutical equipment sector is composed of four engineering technology centers, including biopharmaceutical, special infusion, traditional Chinese medicine preparation and solid preparation. It has eight product technology branches and five holding companies, integrating the R & D, manufacturing and sales of pharmaceutical equipment. In addition to the production of conventional pharmaceutical equipment, it provides the high-quality service of "pharmaceutical technology, pharmaceutical equipment, pharmaceutical engineering"; at the same time, it provides the whole package service for the construction of chemical medicine, biological medicine, plant medicine factories, and solves all the worries for customers. In the field of medical services, Xinhua medical continues to enhance its brand competitiveness and reputation. With professional investment, construction, operation, procurement and service platform, we will build a modern hospital group with advanced medical concept, cutting-edge scientific research level, brand management chain and organic integration of resources. At the same time, Xinhua medical is also actively expanding kidney health services, taking advantage of the company's professional, intensive and chain operation advantages to provide new technology, new management and new mode for the hospital, creating a series of distinctive kidney disease specialized hospitals and hemodialysis centers, serving the vast number of nephrotic patients with unlimited sense of responsibility and professionalism. In the future, Xinhua medical will take a new look of collectivization, specialization and standardization to provide more patients with perfect medical services and achieve the grand dream of developing health industry. The company takes the core area of Shandong Province as its R & D, manufacturing, marketing and management headquarters, and has the core areas of Beijing and Shanghai. Heart health, integrity world. Standing at a new historical starting point and facing new development opportunities, Xinhua medical will, as always, keep pace with the times, bravely face difficulties and challenges with self-confidence, innovation and hard work, and continue to strive for the cause of human health, the building of a monument of China's medical device industry and the building of a world-famous medical device manufacturer!

本文链接: https://www.waitui.com/brand/f0c49f885.html 联系电话:0533-3583393

千城特选小程序码

7×24h 快讯

姚伟雄先生将不再担任安踏集团时尚运动品牌群 CEO 职务,江艳女士将接任时尚运动品牌群 CEO

36氪获悉,因已届退休年龄,姚伟雄先生将不再担任安踏集团时尚运动品牌群 CEO 职务,未来他将继续担任集团副总裁,负责集团时尚产业项目的日常管理与运营。自 2010 年起,姚伟雄先生一直负责 FILA品牌大中华地区的业务,带领团队将 FILA 打造成中国时尚运动赛道的标杆品牌,跻身中国前五大运动品牌之列。集团高度肯定姚伟雄先生为公司和行业所做出的杰出贡献,并祝愿他在新的岗位继续发挥更多的才能。 江艳女士将接任时尚运动品牌群 CEO,全面负责时尚运动品牌群的经营管理,继续推动 FILA 夯实“高端时尚运动品牌“的心智定位,实现品牌驱动的业务增长。江艳女士是集团长期培养的年轻梯队干部,拥有丰富的品牌管理经验,曾先后操盘 ANTA KIDS FILA FUSION 的品牌管理工作,实现了两个品牌在细分市场的领先心智。她将领导 FILA 进一步拓展在年轻人群中的影响力,为消费者创造更多的价值。

2小时前

国新创投基金启航 首期规模100亿元

中国国新联合部分中央企业、地方国资1月18日在京共同举行国新创投基金合作签约仪式。国新创投基金出资合作单位有中国五矿、中国钢研、中国建材、中国有研、中国电气装备、杭州资本、兴湘集团等,首期规模100亿元,存续期15年,同时将启动杭州、湖南、西安等一批子基金,通过母子基金放大方式,围绕“国家所需、创新所要、基金所能”,坚持投早、投小、投长期、投硬科技,为科技强国建设和新质生产力培育贡献力量。(财联社)

2小时前

新凤鸣入选首批国家工信部“卓越级智能工厂”

近日,新凤鸣集团“化纤全产业链协同智能工厂”入选国家“卓越级智能工厂(第一批)项目名单(共235家)”,是浙江省上榜的13家企业之一,也是化纤行业唯一上榜企业。(证券时报)

2小时前

先锋集团将支付1.06亿美元以和解美国SEC指控

美国证券交易委员会(SEC)当地时间1月17日在一份新闻稿中指出,先锋集团(The Vanguard Group, Inc.)将支付1.0641亿美元,以和解有关其对资本利得分配和税收影响的误导性陈述的指控,这些误导性陈述影响了在应纳税账户中持有先锋投资者目标退休基金(Investor TRFs)的零售投资者。和解金额将分配给受影响的投资者。(财联社)

2小时前

今年首家!千亿公募换帅

2025年开年,公募基金行业迎来今年首次基金公司换帅。1月18日,兴银基金发布基金行业高级管理人员变更公告,公告显示,易勇新任兴银基金总经理,同时,董事长吴若曼不再代为履行总经理职务。 Wind数据显示,截至2024年9月30日,兴银基金旗下公募产品数量54只,公募管理规模为1067.32亿元。根据银河证券数据显示,近二年固收排名40/129,近三年排名32/119,近五年排名9/93,在权益方面,兴银基金近两年排名进入前10%(12/124)。(券商中国)

2小时前

本页详细列出关于伟思VISHEE的品牌信息,含品牌所属公司介绍,伟思VISHEE所处行业的品牌地位及优势。
咨询